title: Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro.
abstract: Indirect evidence suggests that amniotic fluid (AF) may play a role in the pathogenesis of in utero HIV-1 transmission. The purpose of this study was to evaluate the potential innate inhibitory role of AF on HIV replication, which may contribute to protection of the fetus against intrauterine transmission. AF was collected from term HIV-1-negative women undergoing scheduled cesarean section. The inhibitory effect of AF against HIV-1(BA-L) replication was tested in vitro with or without the addition of protease inhibitor cocktail (PIC) in PHA-stimulated PBMC cultures. Quantitative measurement of human neutrophil peptides 1-3 (HNP1-3) was performed on all AF samples, using an ELISA assay. AF exhibited a dose-dependent inhibitory activity against HIV-1(BA-L) replication, with all samples (n=12) reaching significant inhibitory effect using 50% AF. In vitro, this activity decreased over time, but was able to be sustained with the addition of PIC. The HNP1-3 concentration in AF samples (n=12) ranged from undetectable (<41 pg/ml, n=3) to >250,000 pg/ml with a median of 5,146 pg/ml. AF exhibited a significant and dose-dependent innate inhibitory activity against HIV-1 replication, which was present in all AF samples tested. This effect was prolonged in the presence of PIC, suggesting that the inhibitory factor was in the cell-free protein fraction. The HNP1-3 concentration in AF was in the subinhibitory range for HIV with no correlation between its concentration and the HIV-1 inhibitory activity. These data show the presence of a significant innate inhibitory activity against HIV in AF.
authors.affiliation: Department of Pediatrics, Division of Pediatric Infectious Diseases, University of California Los Angeles, Los Angeles, CA 90095-1752, USA.
authors.forename: Azadeh
authors.initials: A
authors.lastname: Farzin
authors.forename: Pamela
authors.initials: P
authors.lastname: Boyer
authors.forename: Bonnie
authors.initials: B
authors.lastname: Ank
authors.forename: Karin
authors.initials: K
authors.lastname: Nielsen-Saines
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Bryson
mesh_terms: D000328:Adult; D000653:Amniotic Fluid / Q000276:immunology* / Q000821:virology; D004306:Dose-Response Relationship, Immunologic; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015497:HIV-1 / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D066298:In Vitro Techniques; D011247:Pregnancy; D014779:Virus Replication / Q000276:immunology; D055815:Young Adult